Soul Biotechnology Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.023515 million compared to USD 0.035293 million a year ago. Net loss was USD 1.03 million compared to USD 0.160404 million a year ago.
For the six months, sales was USD 0.060611 million compared to USD 0.080773 million a year ago. Net loss was USD 1.09 million compared to USD 0.194524 million a year ago.